Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

http://scihub22266oqcxt.onion/ 32395964!ä!32395964       Ned+Tijdschr+Geneeskd 2020 ; 164 (ä): ä Nephropedia Template TP {{tp|p=32395964|t=2020. Do's-and-don'ts bij COVID-19-coagulopathie |pdf=|usr=}}{{32395964}} gab.com Text Do's-and-don'ts bij COVID-19-coagulopathie JO: Ned Tijdschr Geneeskd http://www.kidney.de/pget.php?&tw=1&pmid=32395964 #FOAvip COVID-19 is associated with a high prevalence of activation of the coagulation cascade. It has been suggested that this so-called COVID-19-associated coagulopathy is predictive of a poor outcome and of mortality. Consensus documents on how to manage patients with COVID-19-associated coagulopathy are based on the limited number of mainly retrospective studies that is currently available, and for this reason the recommendations are not always consistent with one another. In this article, we review the first studies into COVID-19-associated coagulopathy and give the most important do's and don'ts for diagnostics and the daily management of coagulopathy and the prevention of complications in patients with, or with strongly-suspected, COVID-19 in Dutch clinical practice. Twit Text FOAVip Do's-and-don'ts bij COVID-19-coagulopathie ????Ned Tijdschr Geneeskd http://www.kidney.de/pget.php?&tw=1&pmid=32395964 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32395964 #FOAvip English Wikipedia <ref>{{Cite pmid|32395964}}</ref> Do's-and-don'ts bij COVID-19-coagulopathie #MMPMID32395964 Klok FA; den Exter PL; Huisman MV; Eikenboom J Ned Tijdschr Geneeskd 2020[Apr]; 164 (ä): ä PMID32395964show ga COVID-19 is associated with a high prevalence of activation of the coagulation cascade. It has been suggested that this so-called COVID-19-associated coagulopathy is predictive of a poor outcome and of mortality. Consensus documents on how to manage patients with COVID-19-associated coagulopathy are based on the limited number of mainly retrospective studies that is currently available, and for this reason the recommendations are not always consistent with one another. In this article, we review the first studies into COVID-19-associated coagulopathy and give the most important do's and don'ts for diagnostics and the daily management of coagulopathy and the prevention of complications in patients with, or with strongly-suspected, COVID-19 in Dutch clinical practice. |*Betacoronavirus[MESH] |Blood Coagulation Disorders/diagnosis/*etiology/prevention & control[MESH] |COVID-19[MESH] |Coronavirus Infections/*blood/complications[MESH] |Humans[MESH] |Pandemics[MESH] |Pneumonia, Viral/*blood/complications[MESH] |Retrospective Studies[MESH]Do's-and-don'ts bij COVID-19-coagulopathie (epmc).pdf DeepDyve Pubget Overpricing